Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: A Gynecologic Oncology Group study - Concepedia

Concepedia

Publication | Closed Access

Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: A Gynecologic Oncology Group study

243

Citations

19

References

2005

Year

Maurie Markman, John A. Blessing, Stephen C. Rubin, Joseph P. Connor, Parviz Hanjani, Steven Waggoner

Gynecologic Oncology

Phase Ii TrialMedicineCancer ManagementGynecologyWeekly PaclitaxelPrimary Peritoneal CancersCancer TreatmentOncologyRadiation OncologyGynecology OncologyOvarian Cancer

References

	Year	Citations

Page 1